Objectives: To evaluate the efficacy of intranasal desmopressin compared with intramuscular diclofenac and combination of both in the treatment of acute renal pain caused by stone disease. Patients and methods: Ninety...Objectives: To evaluate the efficacy of intranasal desmopressin compared with intramuscular diclofenac and combination of both in the treatment of acute renal pain caused by stone disease. Patients and methods: Ninety patients (51 males and 39 females) presented to our hospital emergency department (Al-Yarmouk Teaching Hospital/Baghdad/Iraq) with the diagnosis of acute renal pain caused by urolithiasis. They were randomized into three equal groups;group A received desmopressin 40 μg intranasally (4 puffs, each puff equivalent to 10 micrograms), group B received intramuscular diclofenac 75 mg and group C received both desmopressin and diclofenac. A visual analogue scale was used to assess the pain intensity in the 3 groups at baseline, 10, 20 and 30 min after drugs administration. Results: At presentation, the pain intensity was similar in all three groups. For patients in group A, the initial pain score was 9.5 then it declined to 5.2, 3.7 and 3.7 at 10, 20 and 30 minutes after administration of desmopressin, and for patients in group B, the initial pain score was 9.8 then became 4.6, 2.9 and 2.3 at 10, 20 and 30 minutes after diclofenac, while for patients in group C, the initial pain score was 9.7 then became 4.8, 2.6 and 2.2 at 10, 20 and 30 minutes after administration of desmopressin and diclofenac. Conclusion: 40 μg intranasal desmopressin sprays can be used to relieve pain in patients with acute renal pain either alone or combined with diclofenac.展开更多
This study aimed to evaluate pain intensity in chronic renal patients under hemodialysis during the arteriovenous fistula cannulation. It was a cross-sectional study conducted in a hemodialysis clinic in the second se...This study aimed to evaluate pain intensity in chronic renal patients under hemodialysis during the arteriovenous fistula cannulation. It was a cross-sectional study conducted in a hemodialysis clinic in the second semester of 2014. 70 individuals participated in the research and were assessed by the visual analogue scale. The project was approved with opinion number 453.508-2013. During cannulation, the pain reported was moderate in 58.5% of patients, intense in 30% and mild in 11.5%. There was no association between the occurrence of pain in relation to gender, shift and time of hemodialysis. The study points out to the need for pre-cannulation analgesia to improve comfort during the procedure.展开更多
目的:观察基于加速康复外科(ERAS)理念的护理在肾结石手术患者中的应用效果。方法:选取2022年9月至2023年9月于该院行肾结石手术的80例患者进行前瞻性研究,按照随机数字表法将其分为观察组与对照组各40例。对照组实施常规围术期护理,观...目的:观察基于加速康复外科(ERAS)理念的护理在肾结石手术患者中的应用效果。方法:选取2022年9月至2023年9月于该院行肾结石手术的80例患者进行前瞻性研究,按照随机数字表法将其分为观察组与对照组各40例。对照组实施常规围术期护理,观察组在对照组基础上实施基于ERAS理念的护理,两组均护理1周。比较两组术后不同时间(术后12、24、48 h)疼痛[视觉模拟评分法(VAS)]评分、护理前后负性情绪[焦虑自评量表(SAS)、抑郁自评量表(SDS)]评分,并发症发生率,以及护理满意度。结果:观察组术后12、24、48 h VAS评分均低于对照组,差异有统计学意义(P<0.05);护理后,观察组SAS、SDS评分均低于对照组,差异有统计学意义(P<0.05);观察组并发症发生率为2.50%(1/40),低于对照组的20.00%(8/40),差异有统计学意义(P<0.05);观察组护理满意度为97.50%(39/40),高于对照组的75.00%(30/40),差异有统计学意义(P<0.05)。结论:基于ERAS理念的护理应用于肾结石手术患者可降低术后不同时间疼痛评分、负性情绪评分和并发症发生率,提高护理满意度,效果优于常规围术期护理。展开更多
文摘Objectives: To evaluate the efficacy of intranasal desmopressin compared with intramuscular diclofenac and combination of both in the treatment of acute renal pain caused by stone disease. Patients and methods: Ninety patients (51 males and 39 females) presented to our hospital emergency department (Al-Yarmouk Teaching Hospital/Baghdad/Iraq) with the diagnosis of acute renal pain caused by urolithiasis. They were randomized into three equal groups;group A received desmopressin 40 μg intranasally (4 puffs, each puff equivalent to 10 micrograms), group B received intramuscular diclofenac 75 mg and group C received both desmopressin and diclofenac. A visual analogue scale was used to assess the pain intensity in the 3 groups at baseline, 10, 20 and 30 min after drugs administration. Results: At presentation, the pain intensity was similar in all three groups. For patients in group A, the initial pain score was 9.5 then it declined to 5.2, 3.7 and 3.7 at 10, 20 and 30 minutes after administration of desmopressin, and for patients in group B, the initial pain score was 9.8 then became 4.6, 2.9 and 2.3 at 10, 20 and 30 minutes after diclofenac, while for patients in group C, the initial pain score was 9.7 then became 4.8, 2.6 and 2.2 at 10, 20 and 30 minutes after administration of desmopressin and diclofenac. Conclusion: 40 μg intranasal desmopressin sprays can be used to relieve pain in patients with acute renal pain either alone or combined with diclofenac.
文摘This study aimed to evaluate pain intensity in chronic renal patients under hemodialysis during the arteriovenous fistula cannulation. It was a cross-sectional study conducted in a hemodialysis clinic in the second semester of 2014. 70 individuals participated in the research and were assessed by the visual analogue scale. The project was approved with opinion number 453.508-2013. During cannulation, the pain reported was moderate in 58.5% of patients, intense in 30% and mild in 11.5%. There was no association between the occurrence of pain in relation to gender, shift and time of hemodialysis. The study points out to the need for pre-cannulation analgesia to improve comfort during the procedure.
文摘目的:观察基于加速康复外科(ERAS)理念的护理在肾结石手术患者中的应用效果。方法:选取2022年9月至2023年9月于该院行肾结石手术的80例患者进行前瞻性研究,按照随机数字表法将其分为观察组与对照组各40例。对照组实施常规围术期护理,观察组在对照组基础上实施基于ERAS理念的护理,两组均护理1周。比较两组术后不同时间(术后12、24、48 h)疼痛[视觉模拟评分法(VAS)]评分、护理前后负性情绪[焦虑自评量表(SAS)、抑郁自评量表(SDS)]评分,并发症发生率,以及护理满意度。结果:观察组术后12、24、48 h VAS评分均低于对照组,差异有统计学意义(P<0.05);护理后,观察组SAS、SDS评分均低于对照组,差异有统计学意义(P<0.05);观察组并发症发生率为2.50%(1/40),低于对照组的20.00%(8/40),差异有统计学意义(P<0.05);观察组护理满意度为97.50%(39/40),高于对照组的75.00%(30/40),差异有统计学意义(P<0.05)。结论:基于ERAS理念的护理应用于肾结石手术患者可降低术后不同时间疼痛评分、负性情绪评分和并发症发生率,提高护理满意度,效果优于常规围术期护理。